Staff Login
Japanese
| English
Contact Us
List
Search
Browse
Registration
Statistics
Search
Home
List
Reference
Patent
Reference - List
When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
«
»
15 Hits
Search Condition : Filter (MeSH = Imatinib Mesylate)
Species
Resource
RRC ID
Title
Journal
Published
Link
Human and Animal Cells
44754
Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosis.
PLoS One
2013-1-1
Pubmed
Full text
Human and Animal Cells
44595
Imatinib induces demethylation of miR-203 gene: an epigenetic mechanism of anti-tumor effect of imatinib.
Leuk Res
2013-10-1
Pubmed
Full text
Human and Animal Cells
44196
PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells.
Int J Oncol
2013-2-1
Pubmed
Full text
Human and Animal Cells
43640
Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.
Int J Hematol
2012-2-1
Pubmed
Full text
Human and Animal Cells
43302
MEK inhibitor enhances the inhibitory effect of imatinib on pancreatic cancer cell growth.
Cancer Lett
2008-6-18
Pubmed
Full text
Human and Animal Cells
43204
Mechanisms for the proliferation of eosinophilic leukemia cells by FIP1L1-PDGFRalpha.
Biochem Biophys Res Commun
2008-2-22
Pubmed
Full text
Human and Animal Cells
38228
Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway.
Apoptosis
2010-5-1
Pubmed
Full text
Human and Animal Cells
38152
A novel FRET-based biosensor for the measurement of BCR-ABL activity and its response to drugs in living cells.
Clin Cancer Res
2010-8-1
Pubmed
Full text
Human and Animal Cells
37627
Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Cancer Res
2009-5-1
Pubmed
Full text
Human and Animal Cells
36972
Sensitivity of SNX2-ABL1 toward tyrosine kinase inhibitors distinct from that of BCR-ABL1.
Leuk Res
2014-3-1
Pubmed
Full text
Human and Animal Cells
TCS (RCB0638) Ca Ski (RCB1947)
18640
HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers.
Cancer Res
2011-11-1
Pubmed
Full text
Human and Animal Cells
K562
1383
A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity.
Blood
2004-3-15
Pubmed
Full text
Human and Animal Cells
K562
1345
Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it.
Mol Cell Biochem
2004-3-1
Pubmed
Full text
Human and Animal Cells
K562
1344
Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.
Leuk Res
2004-6-1
Pubmed
Full text
Human and Animal Cells
K562(RCB0027)
1343
Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect.
Anticancer Res
2004-9-1
Pubmed